Search research articles
Contact Us
Filters
Showing results (51-60 of 113) with videos related to
Page
of 12
Sort By:
British Journal of Haematology
|
March 5, 2025
Prevalence of cytopenia(s) and somatic variants in patients with DDX41 mutant germline predisposition syndrome
Yael Kusne, Talha Badar, Terra Lasho, et al.
Leukemia Research
|
November 9, 2015
Detectable FLT3-ITD or RAS mutation at the time of transformation from MDS to AML predicts for very poor outcomes
Talha Badar, Keyur P Patel, Philip A Thompson, et al.
British Journal of Haematology
|
November 17, 2024
Somatic co-alteration signatures are prognostic in high-grade TP53-mutated myeloid neoplasms
Emily O Symes, Peng Wang, Payal Sojitra, et al.
Blood Advances
|
October 13, 2021
Genetic features and clinical outcomes of patients with isolated and comutated DDX41-mutated myeloid neoplasms
Hassan B Alkhateeb, Ahmad Nanaa, David Viswanatha, et al.
Haematologica
|
May 18, 2023
Clinical and molecular correlates of somatic and germline <i>DDX41</i> variants in patients and families with myeloid neoplasms
Talha Badar, Ahmad Nanaa, James M Foran, et al.
Leukemia & Lymphoma
|
October 10, 2025
Clinical outcomes of allogeneic cell transplantation for patients with chronic myeloid leukemia
Benjamin McCormick, Anthony Findley, Kendall Diebold, et al.
British Journal of Haematology
|
May 5, 2023
The clinical and molecular spectrum of ETV6 mutated myeloid neoplasms
Mark Gurney, Ismahene Chekkaf, Anmol Baranwal, et al.
Leukemia
|
February 22, 2023
Survival of TP53-mutated acute myeloid leukemia patients receiving allogeneic stem cell transplantation after first induction or salvage therapy: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND)
Talha Badar, Ehab Atallah, Rory Shallis, et al.
American Journal of Hematology
|
September 4, 2023
Patients with telomere biology disorders show context specific somatic mosaic states with high frequency of U2AF1 variants
Alejandro Ferrer, Terra Lasho, Jenna A Fernandez, et al.
Blood Neoplasia
|
September 8, 2025
Tagraxofusp, a CD123-targeted therapy, for chronic myelomonocytic leukemia: final results of a phase 1/2 study
Mrinal M Patnaik, Haris Ali, Eunice S Wang, et al.
Page
of 12
Search research articles
Search
Showing results (51-60 of 113) with videos related to
Sort By:
Page
of 12
British Journal of Haematology
|
March 5, 2025
Prevalence of cytopenia(s) and somatic variants in patients with DDX41 mutant germline predisposition syndrome
Yael Kusne, Talha Badar, Terra Lasho, et al.
Leukemia Research
|
November 9, 2015
Detectable FLT3-ITD or RAS mutation at the time of transformation from MDS to AML predicts for very poor outcomes
Talha Badar, Keyur P Patel, Philip A Thompson, et al.
British Journal of Haematology
|
November 17, 2024
Somatic co-alteration signatures are prognostic in high-grade TP53-mutated myeloid neoplasms
Emily O Symes, Peng Wang, Payal Sojitra, et al.
Blood Advances
|
October 13, 2021
Genetic features and clinical outcomes of patients with isolated and comutated DDX41-mutated myeloid neoplasms
Hassan B Alkhateeb, Ahmad Nanaa, David Viswanatha, et al.
Haematologica
|
May 18, 2023
Clinical and molecular correlates of somatic and germline <i>DDX41</i> variants in patients and families with myeloid neoplasms
Talha Badar, Ahmad Nanaa, James M Foran, et al.
Leukemia & Lymphoma
|
October 10, 2025
Clinical outcomes of allogeneic cell transplantation for patients with chronic myeloid leukemia
Benjamin McCormick, Anthony Findley, Kendall Diebold, et al.
British Journal of Haematology
|
May 5, 2023
The clinical and molecular spectrum of ETV6 mutated myeloid neoplasms
Mark Gurney, Ismahene Chekkaf, Anmol Baranwal, et al.
Leukemia
|
February 22, 2023
Survival of TP53-mutated acute myeloid leukemia patients receiving allogeneic stem cell transplantation after first induction or salvage therapy: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND)
Talha Badar, Ehab Atallah, Rory Shallis, et al.
American Journal of Hematology
|
September 4, 2023
Patients with telomere biology disorders show context specific somatic mosaic states with high frequency of U2AF1 variants
Alejandro Ferrer, Terra Lasho, Jenna A Fernandez, et al.
Blood Neoplasia
|
September 8, 2025
Tagraxofusp, a CD123-targeted therapy, for chronic myelomonocytic leukemia: final results of a phase 1/2 study
Mrinal M Patnaik, Haris Ali, Eunice S Wang, et al.
Page
of 12